Induced remission of malignant melanoma with actinomycin D. Immunologic implications.

Authors	F M Golomb, A C Solowey, A Postel, S L Gumport, J C Wright
Journal	Cancer (Cancer) Vol. 20 Issue 5 Pg. 656-62 (May 1967) ISSN: 0008-543X [Print] United States
PMID	6024278 (Publication Type: Case Reports, Journal Article)
Chemical References	Dactinomycin
Topics	Adult Chemotherapy, Cancer, Regional Perfusion Dactinomycin (administration & dosage, therapeutic use) Female Follow-Up Studies Humans Hypersensitivity, Delayed Injections, Intravenous Male Melanoma (drug therapy, immunology, pathology) Middle Aged

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!